Valencia Nutrition Ltd
₹ 63.0
-0.52%
05 Jun
- close price
About
Incorporated in 2013, Valencia Nutrition Ltd is in the business of developing, manufacturing, sales & distribution of nutraceutical products[1]
Key Points
- Market Cap ₹ 115 Cr.
- Current Price ₹ 63.0
- High / Low ₹ 97.1 / 47.0
- Stock P/E 111
- Book Value ₹ 23.0
- Dividend Yield 0.00 %
- ROCE 2.62 %
- ROE 2.64 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.73 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Earnings include an other income of Rs.0.84 Cr.
- Company has high debtors of 412 days.
- Working capital days have increased from 566 days to 843 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Other Beverages
Loading peers table ...
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.07 | 0.39 | 0.73 | 0.41 | 1.42 | 2.37 | 0.95 | 0.00 | 1.46 | 1.34 | 8.47 | 6.64 | |
| 1.32 | 1.61 | 2.16 | 1.50 | 3.58 | 6.54 | 3.81 | 0.58 | 2.65 | 2.95 | 7.61 | 5.77 | |
| Operating Profit | -1.25 | -1.22 | -1.43 | -1.09 | -2.16 | -4.17 | -2.86 | -0.58 | -1.19 | -1.61 | 0.86 | 0.87 |
| OPM % | -1,785.71% | -312.82% | -195.89% | -265.85% | -152.11% | -175.95% | -301.05% | -81.51% | -120.15% | 10.15% | 13.10% | |
| 0.00 | 0.00 | 0.01 | 0.01 | 0.08 | 0.00 | -0.49 | 0.00 | 0.00 | 0.31 | 0.58 | 0.84 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.04 | 0.09 | 0.01 | 0.00 | 0.03 | 0.15 | 0.13 |
| Depreciation | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.12 | 0.13 | 0.08 | 0.07 | 0.05 | 0.21 | 0.54 |
| Profit before tax | -1.29 | -1.26 | -1.46 | -1.16 | -2.14 | -4.33 | -3.57 | -0.67 | -1.26 | -1.38 | 1.08 | 1.04 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| -1.29 | -1.26 | -1.47 | -1.16 | -2.14 | -4.34 | -3.58 | -0.66 | -1.26 | -1.38 | 1.07 | 1.04 | |
| EPS in Rs | -129.00 | -126.00 | -29.40 | -19.33 | -30.57 | -3.10 | -2.56 | -0.47 | -0.90 | -0.99 | 0.63 | 0.57 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 48% |
| 3 Years: | 66% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 19% |
| 3 Years: | 41% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 52% |
| 3 Years: | 60% |
| 1 Year: | 16% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.04 | 0.06 | 0.19 | 0.25 | 0.28 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 | 16.98 | 18.32 |
| Reserves | 0.29 | 0.15 | -1.22 | 0.87 | 0.38 | -0.75 | -4.33 | -4.99 | -6.25 | -7.64 | 19.60 | 23.88 |
| 0.08 | 0.08 | 0.99 | 0.18 | 0.18 | 0.65 | 0.56 | 0.60 | 2.18 | 5.34 | 1.49 | 8.94 | |
| 0.10 | 0.23 | 0.37 | 0.32 | 0.57 | 1.32 | 1.86 | 1.24 | 1.26 | 2.71 | 0.35 | 0.42 | |
| Total Liabilities | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 | 51.56 |
| 0.06 | 0.08 | 0.09 | 0.09 | 0.11 | 1.44 | 1.41 | 0.22 | 0.15 | 2.32 | 6.05 | 9.19 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 8.39 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.93 | 10.83 |
| 0.45 | 0.44 | 0.24 | 1.53 | 1.30 | 5.34 | 2.27 | 2.22 | 2.63 | 3.68 | 29.30 | 23.15 | |
| Total Assets | 0.51 | 0.52 | 0.33 | 1.62 | 1.41 | 6.81 | 3.68 | 2.44 | 2.78 | 6.00 | 38.42 | 51.56 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | -1.23 | -1.12 | -1.28 | -2.56 | -4.10 | -2.49 | -1.35 | -1.55 | -0.76 | -15.73 | 0.20 | |
| 0.00 | -0.06 | -0.05 | -0.05 | -0.01 | -2.05 | -0.09 | 1.12 | 0.00 | -2.22 | -10.17 | -19.27 | |
| 0.00 | 1.14 | 1.15 | 2.47 | 1.68 | 8.89 | -0.17 | 0.42 | 1.58 | 3.13 | 33.57 | 11.35 | |
| Net Cash Flow | 0.00 | -0.15 | -0.03 | 1.14 | -0.89 | 2.73 | -2.76 | 0.20 | 0.03 | 0.15 | 7.67 | -7.72 |
| Free Cash Flow | 0.00 | -1.29 | -1.17 | -1.34 | -2.64 | -6.15 | -2.61 | -0.23 | -1.55 | -2.98 | -19.67 | -11.19 |
| CFO/OP | 0% | 101% | 78% | 117% | 118% | 98% | 87% | 233% | 130% | 47% | -1,829% | 23% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 208.57 | 149.74 | 40.00 | 17.80 | 33.42 | 3.08 | 7.68 | 72.50 | 264.22 | 279.24 | 411.72 | |
| Inventory Days | 851.67 | 214.71 | 62.93 | 124.43 | 112.54 | 114.68 | 16.50 | 2,920.00 | 200.39 | 143.54 | 216.24 | 643.95 |
| Days Payable | 182.50 | 118.09 | 132.16 | 82.95 | 63.87 | 48.09 | 115.48 | 8,030.00 | 76.34 | 49.21 | 10.57 | 24.98 |
| Cash Conversion Cycle | 877.74 | 246.36 | -29.22 | 59.28 | 82.08 | 69.67 | -91.30 | 196.55 | 358.54 | 484.91 | 1,030.70 | |
| Working Capital Days | 521.43 | 149.74 | -70.00 | 53.41 | 102.82 | 40.04 | -115.26 | 300.00 | 119.85 | 734.31 | 842.69 | |
| ROCE % | -460.71% | -360.00% | -1,168.00% | -180.95% | -200.00% | -135.55% | -81.26% | -43.71% | -92.65% | -56.13% | 6.29% | 2.62% |
Insights
In beta| Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Employee Count Number |
|
||||||
| Product Portfolio Size Number of SKUs |
|||||||
| Retail Reach Number of Outlets |
|||||||
| Production Capacity Bottles per day |
|||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 ("SEBI Listing Regulations")
1d - VBSWPL allotted 30 lakh shares on June 4, 2026; Valencia stake diluted to 75%.
-
Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Half-Year And Financial Year Ended March 31 2026
28 May - Board approved FY26 results, reappointed internal auditor for 3 years, and noted unmodified audit opinion; fine paid.
-
Disclosure Of Statement Of Deviation Or Variation For The Half-Year And Financial Year Ended March 31 2026 Pursuant To Regulation 32 Of The SEBI (LODR) Regulations 2015
28 May - Valencia Nutrition reported full utilisation of three preferential issue proceeds, with nil deviation, as of March 31, 2026.
-
Disclosure Of Related Party Transactions (RPT) For The Half-Year Ended March 31 2026
28 May - Filed half-yearly related party transaction disclosure for March 31, 2026, alongside audited results.
-
Announcement under Regulation 30 (LODR)-Change in Management
28 May - Board approved FY26 audited standalone and consolidated results, reappointed internal auditor, and noted fine fully paid.
Business Overview:[1][2]
VNL is a BSE Start Up Listed Corporate Company since January 2020. It is an applied biotechnology company focused on research, developing & marketing Ready to Drink nutraceuticals, Ready-to-Mix nutraceuticals (Ease Out Sachets) viz. AL Cans, Sachets, PET bottles, PET Cans, Tetra Pack, and Refreshment Mints etc. to prevent or manage lifestyle related diseases